A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination with Anti-VEGF Therapy in Subjects with Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)(Phase 2). The gene discussed is VEGFA; the disease is Polypoidal choroidal vasculopathy.